There’s a moment every clinical sales professional knows. You’re standing in a hospital corridor, a clinician glances at a result that just came back in twelve minutes instead of twelve hours, and a care decision gets made on the spot. No waiting. No delay. Just answers, right there, right when they’re needed.
That moment is happening more and more. And the numbers are finally catching up to what those of us in the field have been watching unfold for years.
A report published on February 24, 2026 put a figure to it: the point-of-care diagnostics market, currently valued at $54.38 billion, is projected to reach $105.22 billion by 2033. That’s an 8.60% compound annual growth rate, and it’s not slowing down. You can read the full report here.
Why Is This Happening Now?
A few things are converging at once:
- Chronic disease prevalence is climbing
- Populations are aging
- Hospital systems are stretched thin on staffing and time
- The pandemic permanently recalibrated what clinicians expect from diagnostic turnaround
Miniaturization of testing technology and a broader push toward decentralized care have also opened doors that simply didn’t exist before. Testing is moving out of centralized labs and into emergency departments, urgent care clinics, and outpatient settings. The care setting itself is changing, and POC diagnostics is riding that wave.
What This Actually Looks Like From the Field
Tyler Eppes has spent years working alongside hospital systems and clinical teams across diagnostics and healthcare solutions. And what he’ll tell you is that the conversation on the ground has shifted in a pretty fundamental way.
Speed used to be a secondary selling point. Accuracy was king, and rightly so.
But today’s hospital buyers want both, and they’ll push back if you can’t deliver. Procurement teams ask sharper questions now. They want to know:
- how quickly results integrate into their workflow
- how a faster answer affects the next step in a patient’s care pathway
- whether a new solution actually reduces burden on an already overstretched nursing staff
The decision-making table has changed, too. It’s no longer just lab directors in the room. You’re talking to clinical informatics teams, department heads, and administrators who are thinking about throughput and cost in the same breath.
What It Means for Clinical Sales Professionals
The truth is, a spec sheet doesn’t close deals the way it once did. Hospital buyers have access to more information than ever. They’ve grown skeptical of pitches that lead with features and trail off before getting to real-world impact.
The reps building lasting relationships right now are the ones showing up with a genuine understanding of what a 12-minute result means for a nurse’s workflow at 2 AM. They understand reimbursement pressures. They know the difference between what a department head wants to hear and what a CFO needs to see. Tyler Eppes believes the shift from vendor to partner isn’t a tagline. It’s a completely different way of preparing for every single call.
The Bigger Picture
The POC diagnostics boom is real, and the market projections back it up. But numbers like $105 billion don’t mean much if the people selling these solutions aren’t evolving alongside them.
The opportunity is there. It belongs to the reps willing to dig deeper, listen harder, and walk into every hospital room already thinking about the clinician’s next problem, not just their own next close.
Leave a Reply